Stay updated on PTI-801 Safety and Pharmacokinetics in CF Clinical Trial
Sign up to get notified when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.

Latest updates to the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedLocations section expanded with a comprehensive list of sites across US states and Canada, and a Revision: v3.3.3 tag is shown. The HHS Vulnerability Disclosure entry under policy sections was removed.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.0%

- Check43 days agoChange Detected- Page revision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check51 days agoChange DetectedThe government funding operating status notice has been removed, while the rest of the trial details and links remain unchanged.SummaryDifference0.2%

- Check65 days agoChange DetectedThe changes are limited to minor formatting and metadata updates (e.g., last update timestamp and layout) and do not modify core study information such as the study title, purpose, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check93 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference2%

Stay in the know with updates to PTI-801 Safety and Pharmacokinetics in CF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PTI-801 Safety and Pharmacokinetics in CF Clinical Trial page.